drugset / Trial / NCT00182975

Effects of Dehydroepiandrosterone (DHEA) in Humans

NCT00182975

Phase 3 Completed 142 enrolled National Institute on Aging (NIA)
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether bringing back the DHEA levels of older persons to the young range produces beneficial effects.

Timeline

Start
2002-09
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydroepiandrosterone Other / unclassified 50 mg Oral

Indications

No indication recorded.